Home About Us Contact Us

 


 

Table of Content - Volume 18 Issue 3 - June 2021



Comparative study of midazolam and nalbuphine with midazolam and fentanyl for analgesic and sedative effect in patients undergoing awake fiberoptic intubation

 

Nandkumar S1, Vijay Kumar Katla2*

 

1Assistant Professor, Department of Anesthesiology, Dr Patnam Mahender Reddy Institute of Medical Sciences, Chevella Village, Chevella Mandal, Ranga Reddy, Telangana, INDIA.

2Assistant Professor, Department of Anesthesiology, Mahavir Institute of Medical Sciences, Vikarabad, Telangana, INDIA.

Email: nandusangeri@gmail.com

 

Abstract              Background: Awake nasal or oral flexible fiberoptic intubation (AFOI) is the airway management technique of choice in known or anticipated difficult airway, severe cervical stenosis, etc. One challenge associated with this procedure is providing adequate sedation and anxiolysis while maintaining a patent airway and adequate ventilation, especially with difficult or critical airways. Present study was conducted to compare the midazolam and nalbuphine with midazolam and fentanyl for analgesic and sedative effect in patients undergoing awake fiberoptic intubation at our tertiary hospital. Material and Methods:Present study was a prospective, comparative and randomized study, conducted in patients of either gender, 18 - 60 years of age, belonging to ASA-I/II, scheduled for elective surgery under general anaesthesia and willing to participate. 60 patients were randomly allocated into two groups group N and group F by using chit and box method of randomization. Group N patients were given inj. nalbuphine (0.2 mg/kg) intravenous and group F patients were given inj. Fentanyl (2 μ g/kg) intravenous both five mins before intubation. Results: In present study total 60 patients were studied. 30 patients each were allocated to each group (group F and group N). General characteristics such as age, gender, height, weight, ASA status were comparable in both groups and difference was not statistically significant. Haemodynamic parameters (heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, SpO2, EtCO2) were comparable in both groups and difference was not statistically significant. Intubation time (mins) was less in group F as compared to group N and difference was statistically significant. Conclusion: Fentanyl-midazolam combination proved to be superior compared to midazolam plus nalbuphine for awake fiberoptic intubation, provided better sedation and analgesia, obtunded airway reflexes and minimized pressor response to awake fiberoptic intubation and provided better patient comfort.

Keywords: midazolam, nalbuphine, fentanyl, awake fiberoptic intubation, total comfort score, Ramsay sedation scale

 

INTRODUCTION

Awake nasal or oral flexible fiberoptic intubation (AFOI) is the airway management technique of choice in known or anticipated difficult airway, severe cervical stenosis, Chiari malformation, unstable cervical fracture, limited mouth opening as in temporomandibular disease, mandibular-maxillary fixation, severe facial burn and vertebral artery insufficiency.1 Fiberoptic intubation has become the instrument of first choice in difficult intubation cases particularly after the publication of the American society of Anesthesiologists (ASA) guidelines in Difficult Airway Management.2 One challenge associated with this procedure is providing adequate sedation and anxiolysis while maintaining a patent airway and adequate ventilation, especially with difficult or critical airways. The main goal of conscious sedation for the patient is that he has to be awake, calm and cooperative, following our verbal commands. Hence there is need for an ideal sedation regimen which would provide patient comfort, blunting of airway reflexes, patient cooperation, hemodynamic stability, amnesia and maintenance of a patent airway with spontaneous ventilation. Fentanyl, is a synthetic narcotic analgesic, with rapid onset and short duration of action, routinely used for intravenous analgesia. It has proved to be very effective to control short term hemodynamic change.4 Nalbuphine is agonist at κ receptor and acts as antagonist at μ receptor. It is also effective in suppressing the hemodynamic changes during airway stimulation. Its cardiovascular stability, long duration of analgesia, lack of respiratory depression and decreased incidences of nausea and vomiting, makes it an ideal analgesic during anaesthesia.5 Present study was conducted to compare the midazolam and nalbuphine with midazolam and fentanyl for analgesic and sedative effect in patients undergoing awake fiberoptic intubation at our tertiary hospital.

              

MATERIAL AND METHODS

Present study was a prospective, comparative and randomized study, conducted in Department of Anesthesiology, Dr Patnam Mahender Reddy Institute of Medical Sciences. Study approval was taken from ethical committee. Study period was of 1 year (from July 2019 to June 2020).

Inclusion criteria

Patients of either gender, 18 - 60 years of age, belonging to ASA-I/II, scheduled for elective surgery under general anaesthesia and willing to participate.

Exclusion criteria: Emergency surgery, severe bradycardia/heart block, pregnant patients, patients having known allergy to any drugs used in the study, patients on longterm opioids or sedative medications, patients with grossly distorted airway anatomy and bleeding disorders. Patient refusal, lack of understanding or psychiatric patients, All patients received injection of glycopyrrolate (0.2 mg) as premedication 30 min before the procedure and 2% lignocaine viscous gargles were done to achieve adequate topical anaesthesia. Inj. midazolam 0.05mg/kg was given 15 mins prior to intubation. Nasal mucosa was sprayed with xylometazoline 0.1% vasoconstrictor and two puffs of 10% lignocaine. A nasopharyngeal dilator with lignocaine jelly was introduced. For further topical anaesthesia two puffs of 10% lignocaine were sprayed to tonsillar pillars and back of the throat. Transtracheal block was performed by piercing the cricothyroid membrane in the midline of the neck with 4 ml of 4% lignocaine. 60 patients were Two groups of 50 each were studied. Group-DK and group-DP patient received IV dexmedetomidine 1μg/kg over 10 mins. Upon completion of the dexmedetomidine bolus, preoxygenation was done with 100% oxygen via face mask with Bain’s circuit. Group-DK patients received ketamine 0.25 mg/kg IV and Group-DP patients received propofol 1mg/kg IV so as to achieve an adequate level of sedation i.e. Ramsay sedation scale=3 (patients responded to command only). The patients were randomly allocated into two groups group N and group F by using chit and box method of randomization. Group N patients were given inj. nalbuphine (0.2 mg/kg) intravenous and group F patients were given inj. Fentanyl (2 μ g/kg) intravenous both five mins before intubation. Fibreoptic nasotracheal intubation was carried out in both groups of patients. Once tracheal intubation was completed and the tube was secured, general anaesthesia was administered. Haemodynamic parameters (heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, SpO2, EtCO2), comfort score and patient’s reaction to placement of endotracheal tube (VAS) were recorded during preoxygenation, fiberscope insertion (1,2,3,4 and 5 min. intervals) and endotracheal intubation (1,2,3,4 and 5 min. intervals). The total comfort score for each patient was calculated by summing the scores of the seven comfort categories at each time point. The total score was 35.


 

Table 1: Total comfort score

Parameter

1

2

3

4

5

Alertness

Deeply asleep

Lightly asleep

Drowsy

Fully awake and alert

Hyper-alert

Calmness

Calm

Slightly anxious

Anxious

Very anxious

panicky

Respiratory response

No coughing and no spontaneous respiration

Spontaneous respiration

Occasional cough

Coughing regularly

Frequent coughing or choking

Crying

Quiet breathing, no crying

Sobbing or gasping

Moaning

Crying

Screaming

Physical movement

No movement

Frequent slight movement

Vigorous movement limited to extremities

Vigorous

movements including torso and head

Occasional slight movement

Muscle movement

Muscles totally relaxed, no muscle movement

Reduced muscle tone

Normal muscle tone

Increased muscle tone and flexing of fingers and toes

Extreme muscle rigidity and flexing of fingers and toes

Facial tension

Facial muscle totally relaxed

No facial tension evident

Tension evident throughout facial muscle

Facial muscle contorted

Grimacing

Patient's tolerance6 was assessed by an independent observer on the basis of 5 point Fiber Optic Index (FOI) score: No reaction (1); Slight grimacing (2); Severe grimacing (3); Verbal objection (4); Defensive movement of head, hands or feet (5). Level of sedation was evaluated by Ramsay sedation score (RSS) just after completion of infusion of study drug as: 1 = Anxious, agitated or restless, 2 = cooperative, oriented and tranquil, 3 = sedated but responds to command, 4 = asleep, brisk glabellar reflex responds to loud noise, 5 = asleep, sluggish glabellar reflex or responds to loud noise, 6 = asleep with no response to a painful stimulus. The data was analyzed using SPSS version 22 and Microsoft Excel. Descriptive statistics was done for all data and reported in terms of mean and percentages. Appropriated statistical tests of comparison were applied. Continuous variables were analyzed with Mann Whitney U test and t test. Categorical variables were analyzed with the help of chi square test. Statistical significance was taken as p<0.05.

 

RESULTS

In present study total 60 patients were studied. 30 patients each were allocated to each group (group F and group N). General characteristics such as age, gender, height, weight, ASA status were comparable in both groups and difference was not statistically significant.

Table 2: General characteristic

Parameter

Group F (Mean ± SD)

Group N (Mean ± SD)

P value

Age (in years)

46.6 ± 12.4

47.4 ±10.6

0.66

Gender

 

 

0.69

Male

17 (57%)

16 (53%)

 

Female

13 (43%)

14 (47%)

 

Weight (kg)

57.3 ± 12.1

58.8 ± 11.3

0.49

Height (cm)

162.7 ± 10.2

161.2± 9.6

0.57

ASA status

 

 

0.72

I

19 (63%)

20 (67%)

 

II

11 (37%)

10 (33%)

 

Haemodynamic parameters (heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, SpO2, EtCO2) were comparable in both groups and difference was not statistically significant. Intubation time (mins) was less in group F as compared to group N and difference was statistically significant. VAS score during ET was comparable in both groups. Total comfort score (during preoxygenation, FOS and ET), Ramsay sedation scale and Patients tolerance (FOS, ET) was better in group F as compared to group N and difference was statistically significant.

 

Table 3: Study parameters

Parameters

Group F (Mean ± SD)

Group N (Mean ± SD)

p-value

Intubation time(mins)

3.95 ± 0.82

4.67 ± 0.68

0.042

VAS score - During ET

2.19 ± 0.45

2.08 ± 0.58

0.58

Total comfort score

 

 

 

During Preoxygenation

14.12 ± 1.29

14.97 ± 1.38

0.64

During FOS

14.38 ± 1.58

15.70 ± 1.43

0.015

During ET

14.80 ± 1.51

16.04 ± 1.26

0.034

Ramsay sedation scale (RSS)

2.78 ± 0.71

2.21 ± 0.54

0.001

Patients tolerance

 

 

 

FOS

3.18 ± 0.27

3.63 ± 0.46

0.023

ET

2.44 ± 0.45

2.94 ± 0.65

0.012

 


DISCUSSION

Awake fiberoptic intubation (AFOI) is indicated for patients with anticipated difficult airways because of their anatomy, airway trauma, morbid obesity, and unstable cervical spine injuries. One challenge associated with this procedure is providing adequate sedation and anxiolysis while maintaining a patent airway and adequate ventilation, especially with difficult or critical airways. The flexibility and versatility of fiberoptic endoscopy allows dynamic assessment of the airway anatomy in the supraglottic and subglottic region in an atraumatic fashion. Further Awake Fiberoptic Intubation is safe with a higher success rate due to the preserved Muscle tone avoids airway collapse and keeps the airway patent, spontaneous breathing on command can open the obstructed airway passages and chances of desaturation is minimal in awake state/spontaneous breathing.2 An ideal sedative is expected to provide comfort and elicit patient cooperation while maintaining hemodynamic stability and spontaneous ventilation. Drugs used for sedation during awake fiberoptic intubation include midazolam, diazepam, ketamine, propofol, sevoflurane, fentanyl, remifentanil and dexmedetomidine. etc.3 Midazolam is an ultra-short-acting benzodiazepine derivative. It has potent anxiolytic, amnesic, hypnotic, anticonvulsant, skeletal muscle relaxant, and sedative properties. Ojaswani RS et al.,7 studied 60 patients who were randomly divided into group N (n=30) received inj. nalbuphine 0.2 mg/kg i.v. and group B (n=30) received inj. fentanyl 2 mcg/kg i.v., both 5 mins prior to the introduction of fiberscope. Group F patients had better sedation score, VAS score, significantly better intubation score, intubation time and patient comfort score. Hemodynamics (heart rate, systolic blood pressure, diastolic blood pressure) were significantly better in group F. They concluded that fentanyl-midazolam combination for awake fiberoptic intubation, provided better sedation and analgesia, obtunded airway reflexes and minimized pressor response to awake fiberoptic intubation and provided better patient comfort. Similar findings were noted in present study. Dhasmana S et al.,8 noted that fentanyl with midazolam improved the quality of sedation, provides good anxiolysis and amnesia without cardiorespiratory depression. This combination has been proved to provide better patient comfort and sedation in patients undergoing awake blind nasotracheal intubation Kaur S er al.,9 studied 100 patients and compared intubating conditions using fentanyl plus propofol versus nalbuphine plus propofol during fiberoptic intubation. A significant difference between two groups in terms of HR, SBP, DBP, MAP, total comfort score and patient tolerance was noted during fiberscope insertion and endotracheal intubation. Fentanyl plus propofol regimes are suitable for fiberoptic intubation. Fentanyl plus propofol appeared to offer better tolerance, preservation of an airway and spontaneous ventilation, while maintaining haemodynamic stability. Parmod Kumar et al.,10 noted that fentanyl plus midazolam group showed better patient comfort and maintenance of oxygen saturation than fentanyl plus propofol group during fiberoptic intubation. Both fentanyl plus midazolam and fentanyl plus propofol regimes are suitable for fiberoptic intubation. Fentanyl plus midazolam appeared to offer better tolerance, preservation of an airway and spontaneous ventilation, while maintaining haemodynamic stability. While other authors noted that nalbuphine provides good hemodynamic and excellent post-operative analgesia which is comparable to fentanyl but at a less frequent dosing thus decreasing the overall opioid requirement for general anesthesia,11,12 which is not coinciding with present study findings. Limitations of present study were small sample size, variation between patients pain threshold and study was limited scheduled for elective surgery without comorbidities. Further studies are recommended to know the effect of studied drugs on comorbidities such as diabetes or hypertension.

 

CONCLUSION

Nalbuphine and fentanyl were effective in controlling the haemodynamic response to stress of endotracheal intubation. However, fentanyl-midazolam combination proved to be superior compared to midazolam plus nalbuphine for awake fiberoptic intubation, provided better sedation and analgesia, obtunded airway reflexes and minimized pressor response to awake fiberoptic intubation and provided better patient comfort.

 

REFERENCES

  1. Artime C. Flexible fiberoptic intubation. In: Hagberg CA, Daily WH, eds. The difficult airway: a practical guide. Oxford University Press 2013.
  2. Dorsch JA, Dorsch SE. Tracheal tubes. In:Dorsch JA, Dorsch SE(eds). Understanding anaesthesia equipment, 5th edition. Philadelphia:Lippincott Williams and Wilkins;2007
  3. Rai MR, Parry TM, Dombrovskis A, et al. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fiberoptic intubation: a double-blinded randomized controlled trial. Bri J Anaesth 2008;100(1):125-30.
  4. Swegle JM, Gemann CL. Management of common opioid induced adverse effects. Am Fam Physician. 2006;74:1347–54.
  5. Freye E, Levy JV. Reflex activity caused by laryngoscopy and intubation is obtunded differently by meptazinol, nalbuphine and fentanyl. Eur J Anaesthesiol. 2007;24:53-8.
  6. Ambuel B, Hamlett KW, Marx CM, Blumer JL. Assessing distress in Pediatric Intensive Care Env: The Comfort Scale. J Pediatr Psychol. 1992;17(1):95-109.
  7. Ojaswani RS, Jaspreet. A prospective randomized study to compare analgesic and sedative effect of midazolam and nalbuphine with midazolam and fentanyl in patients undergoing awake fiberoptic intubation. Indian J Clin Anaesth 2019;6(2):235-41.
  8. Dhasmana S, Singh V, Pal US. Awake Blind Nasotracheal Intubation in Temporomandibular Joint Ankylosis Patients under Conscious Sedation Using Fentanyl and Midazolam. J Maxillofac Oral Surg 2010;9(4):377-81.
  9. Kaur S, Chawla D, Kumar P, et al. To evaluate the comparison of intubating conditions using fentanyl plus propofol versus nalbuphine plus propofol during fiberoptic intubation. J. Evolution Med. Dent. Sci. 2018;7(51):6230-6236.
  10. Parmod Kumar, Tripat Kaur, Gurpreet Kaur Atwal, Jatinderpaul Singh Bhupal Ajay Kumar Basra, Comparison of intubating conditions using fentanyl plus propofol versus fentanyl plus midazolam during fiberoptic laryngoscopy, Journal of Clinical and Diagnostic Research. 2017 Jul, Vol-11(7): UC21-UC24.
  11. Buchh A, Gupta K, Sharma D, Anwar U, Pandey MN, Kalra P. Comparative evaluation of fentanyl versus nalbuphine for attenuation of hemodynamic changes during airway stimulation. Int J Res Med Sci 2018;6:632-8.
  12. Hari Prasad K, Ram Kumar P.A, Rajagokilam R Vinithra Varadarajan. A comparative study of analgesic potential of nalbuphine versus fentanyl during general anaesthesia. International Journal of Contemporary Medical Research 2016;3(10):2815-2818.


 












 


 

 


 

 











 



 








 





Policy for Articles with Open Access:

Authors who publish with MedPulse International Journal of Pediatrics (Print ISSN: 2579-0897) (Online ISSN: 2636-4662) agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.